MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$183,903K
Net Income
$30,348K
Net Profit Margin
16.50%
EPS
$0.67
Unit: Thousand (K) dollars
Revenue Breakdown
US
FR
CN
Revenue Breakdown
Other Products
Baqsimi
Primatenemist
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Revenues
183,903
171,171
183,105
191,840
Cost of revenues
90,433
100,849
97,435
93,194
Gross profit
93,470
70,322
85,670
98,646
Selling, distribution, and marketing
13,335
11,927
10,279
11,505
General and administrative
18,242
18,028
16,471
39,467
Research and development
22,164
26,737
23,314
22,354
Total operating expenses
53,741
56,692
50,064
73,326
Income from operations
39,729
13,630
35,606
25,320
Interest income
2,287
2,400
2,423
2,246
Interest expense
6,659
6,553
6,630
6,284
Other income (expenses), net
3,187
575
515
231
Total non-operating income (expenses), net
-1,185
-3,578
-3,692
-3,807
Income before income taxes
38,544
10,052
31,914
21,513
Income tax provision
8,196
3,632
7,485
4,163
Income before equity in losses of unconsolidated affiliate
-
-
24,429
17,350
Net income
30,348
6,420
24,429
17,350
Basic EPS
0.69
0.14
0.532
0.38
Diluted EPS
0.67
0.14
0.518
0.37
Basic Average Shares
43,644,000
45,322,000
45,908,000
46,474,000
Diluted Average Shares
44,225,000
46,458,000
47,165,000
47,677,000
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
1
2
US
$172,342K
(3.20%↑ Y/Y)
FR
$7,001K
(-1.57%↓ Y/Y)
CN
$4,560K
(1425.08%↑ Y/Y)
Revenues
$183,903K
(5.44%↑ Y/Y)
Gross profit
$93,470K
(8.07%↑ Y/Y)
Cost of revenues
$90,433K
(2.85%↑ Y/Y)
Income from operations
$39,729K
(-5.82%↓ Y/Y)
Total operating
expenses
$53,741K
(21.30%↑ Y/Y)
Income before income
taxes
$38,544K
(-2.01%↓ Y/Y)
Total non-operating
income (expenses), net
-$1,185K
(58.41%↑ Y/Y)
Other income
(expenses), net
$3,187K
(110.92%↑ Y/Y)
Interest income
$2,287K
(19.05%↑ Y/Y)
Research and development
$22,164K
(10.38%↑ Y/Y)
General and
administrative
$18,242K
(30.38%↑ Y/Y)
Selling, distribution,
and marketing
$13,335K
(30.29%↑ Y/Y)
Net income
$30,348K
(-2.20%↓ Y/Y)
Income tax provision
$8,196K
(-1.31%↓ Y/Y)
Interest expense
$6,659K
(6.02%↑ Y/Y)
Buy us a coffee
Amphastar Pharmaceuticals, Inc. (AMPH)
Amphastar Pharmaceuticals, Inc. (AMPH)